Table 3

Mean annual ingredient cost of chronic comorbidity in the study population with and without T2DM
Sex Age (yrs) T2DM group Non T2DM group Cost ratio*
Male
65-69 1183. 43 [1182.12, 1184.75] 683. 85 [683.41, 684.28] 1.73
70-74 1184. 35 [1183.22, 1185.47] 744. 02 [743.67, 744.37] 1.59
≥75 1245. 51 [1244.65, 1246.36] 871. 33 [871.02, 871.65] 1.45
Female
65-69 1223. 89 [1222.43, 1225.31] 667.52 [667.16, 667.88] 1.83
70-74 1293. 06 [1291.74, 1294.38] 764.89 [764.57, 765.22] 1.69
≥75 1279. 10 [1278.05, 1280.14] 882.95 [882.71, 883.18] 1.45
No. of comorbid conditions
0 0 0 1
1 193. 45 [192.82, 194.08] 225.02 [224.86, 225.17] 0.86
2 386. 59 [385.99, 387.20] 414.52 [414.34, 414.69] 0.93
3 628. 65 [628.10, 629.21] 628.35 [628.15, 628.54] 1
4 897. 08 [896.42, 897.74] 874.86 [874.60, 875.11] 1.03
5 1186. 88 [1186.14, 1187.62] 1153.70 [1153.38, 1154.02] 1.03
6 1485. 14 [1484.16, 1486.13] 1454.08 [1153.38, 1154.02] 1.02
7 1807.74 [1806.40, 1809.08] 1764.68 [1764.05, 1765.31] 1.02
8 2130. 86 [2129.05, 2132.67] 2078.91 [2078.03, 2079.79] 1.03
9 2461. 44 [2458.71, 2464.17] 2436.44 [2435.00, 2437.87] 1.01
≥10 3151. 03 [3146.39, 3155.67] 3023.80 [3022.13, 3025.46] 1.04

[95% Confidence Interval].

* T2DM group : non T2DM group.

O’Shea et al.

O’Shea et al. BMC Health Services Research 2013 13:23   doi:10.1186/1472-6963-13-23

Open Data